Although the futuristic-looking Toyota Prius wins in a swimsuit competition, the sturdy design and fun-to-drive factor of the ...

The Honda Gold Wing is synonymous with comfortable open road motorcycle touring. But when it debuted 50 years ago, it was not ...

The deal, which is expected to close in 2025’s third quarter, will set up Tanabe Pharma as an independent company poised to benefit from Bain’s financial firepower and biopharma know-how ...

Combining daily usability with racing car performance, the BMW M3 CS Touring will ensure that your children are never late for school again. BMW's lineup already benefits from having two unique ...

This resiliency points to something crucial: an American civic culture which, while battered and never perfect, holds us together. I believe it’s time to be more intentional about this culture ...

Founded in 1678, Tanabe Pharma is headquartered in Doshomachi, Osaka, the birthplace of Japan’s pharmaceutical industry. Through the discovery and development of innovative drugs that address ...

As a Hispanic-serving institution, one focus of CSUF’s Civic and Voter Empowerment Action Plan for 2024-26 was to involve Latinx students, who make up more than 50% of the university’s 42,000 ...

TOKYO, Feb 7 (Reuters) - U.S. private equity firm Bain Capital has bought Mitsubishi Tanabe Pharma in a deal worth 510 billion yen ($3.4 billion), saying it was encouraged by prospects of ...

TOKYO :U.S. private equity firm Bain Capital has bought Mitsubishi Tanabe Pharma in a deal worth 510 billion yen ($3.4 billion), saying it was encouraged by prospects of regulatory change for ...

According to Mitsubishi Chemical Group financial reports, Tanabe Pharma generated 437.4 billion yen (about $2.89 billion) in revenue for the fiscal year ended March 31, 2024. That’s down 18.3% ...

Knowing this, a rapidly up-and-coming semi-pro racer and YouTuber Eric Kutil might've built a gen-V Civic-based race car that does tributes just that. Eric's day job is running the Hybrid Racing ...

The U.S. investment company is in the final stages of negotiations to buy the subsidiary, Mitsubishi Tanabe Pharma, for possibly more than 500 billion yen, equivalent to $3.21 billion, the person ...